Altamira Therapeutics Ltd. Interest Paid Classified As Financing Activities
Altamira Therapeutics Ltd. (CYTOF) reported Interest Paid Classified As Financing Activities of $7.32 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:InterestPaidClassifiedAsFinancingActivities · last filed 2025-08-29
CHF
| Period end | Interest Paid Classified As Financing Activities 6 month | Interest Paid Classified As Financing Activities 12 month |
|---|---|---|
| 2023-12-31 | 148.34K CHF 20-F/A · filed 2024-04-22 | |
| 2023-06-30 | 19.34K CHF 6-K · filed 2023-09-12 | |
| 2022-12-31 | 19.50K CHF 20-F/A · filed 2024-04-22 | |
| 2022-06-30 | 8.41K CHF 6-K · filed 2023-09-12 | |
| 2021-12-31 | 3.70K CHF 20-F/A · filed 2024-04-22 | |
| 2021-06-30 | 13.00 CHF 6-K/A · filed 2023-08-21 | |
| 2019-12-31 | 3.75K CHF 20-F · filed 2022-04-12 | |
| 2019-06-30 | 3.75K CHF 6-K/A · filed 2020-09-17 | |
| 2018-12-31 | 435.99K CHF 20-F · filed 2021-03-31 | |
| 2018-06-30 | 339.05K CHF 6-K · filed 2019-08-15 | |
| 2017-12-31 | 1.18M CHF 20-F · filed 2020-04-16 | |
| 2016-12-31 | 546.17K CHF 20-F · filed 2019-03-14 | |
| 2015-12-31 | 172.00 CHF 20-F · filed 2018-03-22 |
USD
| Period end | Interest Paid Classified As Financing Activities 6 month | Interest Paid Classified As Financing Activities 12 month |
|---|---|---|
| 2025-06-30 | $7.32K 6-K · filed 2025-08-29 | |
| 2024-12-31 | $11.69K 20-F · filed 2025-04-30 | |
| 2024-06-30 | $3.34K 6-K · filed 2025-08-29 | |
| 2023-12-31 | $165.10K 20-F · filed 2025-04-30 | |
| 2023-06-30 | $21.20K 6-K · filed 2024-09-24 | |
| 2022-12-31 | $20.42K 20-F · filed 2025-04-30 |